Exosomes as nano-theranostic delivery platforms for gene therapy

Advanced Drug Delivery Reviews

Volumn 65, Issue 3, 2013, Pages 357-367

  Tan, Aaron ^a   Rajadas, Jayakumar ^b   Seifalian, Alexander M ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Drug delivery; Exosomes; Gene therapy; Nanotechnology; Theranostic

Indexed keywords

BIOLOGICAL CELLS; BIOLOGICAL FUNCTIONS; CELL-TO-CELL COMMUNICATION; EXOSOMES; GENETIC MATERIALS; PHYSIOLOGICAL FUNCTIONS; THERANOSTIC; TRANSFECTION EFFICIENCY;

BIOLOGICAL MEMBRANES; CYTOLOGY; DIAGNOSIS; DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY; RNA; VIRUSES;

GENE THERAPY;

LIPID; MESSENGER RNA; MICRORNA; NANOTUBE; POLYMER; RNA; SMALL INTERFERING RNA; TETRASPANIN;

B LYMPHOCYTE; CELL COMMUNICATION; DENDRITIC CELL; DRUG DELIVERY SYSTEM; EXOSOME; GENE THERAPY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; NANOMEDICINE; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL COMMUNICATION; EXOSOMES; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; IMMUNE SYSTEM; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; TRANSFECTION;

EID: 84874957913     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.06.014     Document Type: Review

References (97)

1. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
2. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
3. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misjak P., Aradi B., et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011, 68:2667-2688.
4. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345.
5. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21.
6. Tan A., Yildirimer L., Rajadas J., De La Pena H., Pastorin G., Seifalian A. Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine (Lond) 2011, 6:1101-1114.
7. Faustine J.Tani, Sufian J.T. Updates on current advances in gene therapy. West Indian Med J 2011, 60:188-194.
8. Cellular and Gene Therapy Products. FDA Website:, [assessed 26 May 2012]. http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/default.htm.
9. Pearson S., Jia H., Kandachi K. China approves first gene therapy. Nat Biotechnol 2004, 22:3-4.
10. Chen S., Chen J., Ma G., Xi W., Xu Q., Xu W., et al. Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma. Am J Clin Oncol 2011, 10.1097/COC.0b013e3181fe4688.
11. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 2008, 358:2231-2239.
12. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008, 358:2240-2248.
13. Seow Y., Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol Ther 2009, 17:767-777.
14. Gao J., Yu Y., Zhang Y., Song J., Chen H., Li W., et al. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 2012, 33:270-282.
15. Zeng X., Pan S., Li J., Wang C., Wen Y., Wu H., et al. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector. Nanotechnology 2011, 22:375102.
16. Kam N.W., Liu Z., Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005, 127:12492-12493.
17. Bonner D.K., Leung C., Chen-Liang J., Chingozha L., Langer R., Hammond P.T. Intracellular trafficking of polyamidoamine-poly(ethylene glycol) block copolymers in DNA delivery. Bioconjug Chem 2011, 22:1519-1525.
18. Lytton-Jean A.K., Langer R., Anderson D.G. Five years of siRNA delivery: spotlight on gold nanoparticles. Small 2011, 7:1932-1937.
19. Meckes D.G., Shair K.H., Marquitz A.R., Kung C.P., Edwards R.H., Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci U S A 2010, 107:20370-20375.
20. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
21. Orr L., Adam M., Johnstone R.M. Externalization of membrane-bound activities during sheep reticulocyte maturation is temperature and ATP dependent. Biochem Cell Biol 1987, 65:1080-1090.
22. Mitchell P., Petfalski E., Shevchenko A., Mann M., Tollervey D. The exosome: a conserved eukaryotic RNA processing complex containing multiple 3'->5' exoribonucleases. Cell 1997, 91:457-466.
23. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010, 78:838-848.
24. Camussi G., Deregibus M.C., Bruno S., Grange C., Fonsato V., Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011, 1:98-110.
25. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
26. Escrevente C., Keller S., Altevogt P., Costa J. Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 2011, 11:108.
27. Tian T., Wang Y., Wang H., Zhu Z., Xiao Z. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy. J Cell Biochem 2010, 111:488-496.
28. Gould S.J., Booth A.M., Hildreth J.E. The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 2003, 100:10592-10597.
29. Thery C, Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids, Current protocols in cell biology/editorial board, Juan S. Bonifacino ... [et al.], Chapter 3 (2006) Unit 3 2.
30. Schorey J.S., Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9:871-881.
31. Pan B.T., Teng K., Wu C., Adam M., Johnstone R.M. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985, 101:942-948.
32. Pan B.T., Johnstone R.M. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983, 33:967-978.
33. Petersen S.H., Odintsova E., Haigh T.A., Rickinson A.B., Taylor G.S., Berditchevski F. The role of tetraspanin CD63 in antigen presentation via MHC class II. Eur J Immunol 2011, 41:2556-2561.
34. Quesenberry P.J., Aliotta J.M. Cellular phenotype switching and microvesicles. Adv Drug Deliv Rev 2010, 62:1141-1148.
35. Qazi K.R., Gehrmann U., Domange Jordo E., Karlsson M.C., Gabrielsson S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 2009, 113:2673-2683.
36. Buning J., von Smolinski D., Tafazzoli K., Zimmer K.P., Strobel S., Apostolaki M., et al. Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes. Immunology 2008, 125:510-521.
37. Johansson S.M., Admyre C., Scheynius A., Gabrielsson S. Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology 2008, 123:491-499.
38. Rountree R.B., Mandl S.J., Nachtwey J.M., Dalpozzo K., Do L., Lombardo J.R., et al. Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy. Cancer Res 2011, 71:5235-5244.
39. Hao S., Liu Y., Yuan J., Zhang X., He T., Wu X., et al. Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses. J Immunol 2007, 179:2731-2740.
40. Viaud S., Terme M., Flament C., Taieb J., Andre F., Novault S., et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS One 2009, 4:e4942.
41. Dai S., Wei D., Wu Z., Zhou X., Wei X., Huang H., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther 2008, 16:782-790.
42. Escudier B., Dorval T., Chaput N., Andre F., Caby M.P., Novault S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 2005, 3:10.
43. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 2005, 3:9.
44. Mincheva-Nilsson L., Baranov V. The role of placental exosomes in reproduction. Am J Reprod Immunol 2010, 63:520-533.
45. Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 2009, 183:340-351.
46. Mincheva-Nilsson L., Nagaeva O., Chen T., Stendahl U., Antsiferova J., Mogren I., et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol 2006, 176:3585-3592.
47. Sabapatha A., Gercel-Taylor C., Taylor D.D. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol 2006, 56:345-355.
48. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 2010, 4:214-222.
49. Potolicchio I., Carven G.J., Xu X., Stipp C., Riese R.J., Stern L.J., et al. Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J Immunol 2005, 175:2237-2243.
50. Kramer-Albers E.M., Bretz N., Tenzer S., Winterstein C., Mobius W., Berger H., et al. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons?. Proteomics Clin Appl 2007, 1:1446-1461.
51. Lachenal G., Pernet-Gallay K., Chivet M., Hemming F.J., Belly A., Bodon G., et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011, 46:409-418.
52. Muller G., Schneider M., Biemer-Daub G., Wied S. Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol-anchored proteins transfer RNA stimulating lipid synthesis. Cell Signal 2011, 23:1207-1223.
53. Lasser C., Alikhani V.S., Ekstrom K., Eldh M., Paredes P.T., Bossios A., et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 2011, 9:9.
54. Eldh M., Ekstrom K., Valadi H., Sjostrand M., Olsson B., Jernas M., et al. Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One 2010, 5:e15353.
55. Izquierdo-Useros N., Puertas M.C., Borras F.E., Blanco J., Martinez-Picado J. Exosomes and retroviruses: the chicken or the egg?. Cell Microbiol 2011, 13:10-17.
56. Izquierdo-Useros N., Naranjo-Gomez M., Erkizia I., Puertas M.C., Borras F.E., Blanco J., et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?. PLoS Pathog 2010, 6:e1000740.
57. Pelchen-Matthews A., Raposo G., Marsh M. Endosomes, exosomes and Trojan viruses. Trends Microbiol 2004, 12:310-316.
58. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107:6328-6333.
59. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
60. Koumangoye R.B., Sakwe A.M., Goodwin J.S., Patel T., Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 2011, 6:e24234.
61. Yang M., Chen J., Su F., Yu B., Su F., Lin L., et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011, 10:117.
62. Kogure T., Lin W.L., Yan I.K., Braconi C., Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011, 54:1237-1248.
63. Cho J.A., Park H., Lim E.H., Lee K.W. Exosomes from breast cancer cells can convert adipose tissue-derived. Int J Oncol 2012, 40:130-138.
64. Cho J.A., Park H., Lim E.H., Kim K.H., Choi J.S., Lee J.H., et al. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol Oncol 2011, 123:379-386.
65. Nazarenko I., Rana S., Baumann A., McAlear J., Hellwig A., Trendelenburg M., et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res 2010, 70:1668-1678.
66. Aung T., Chapuy B., Vogel D., Wenzel D., Oppermann M., Lahmann M., et al. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A 2011, 108:15336-15341.
67. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004, 101:9683-9688.
68. Vella L.J., Sharples R.A., Lawson V.A., Masters C.L., Cappai R., Hill A.F. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007, 211:582-590.
69. Porto-Carreiro I., Fevrier B., Paquet S., Vilette D., Raposo G. Prions and exosomes: from PrPc trafficking to PrPsc propagation. Blood Cells Mol Dis 2005, 35:143-148.
70. Fevrier B., Vilette D., Laude H., Raposo G. Exosomes: a bubble ride for prions?. Traffic 2005, 6:10-17.
71. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286:2244-2245.
72. Aiuti A., Cattaneo F., Galimberti S., Benninghoff U., Cassani B., Callegaro L., et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009, 360:447-458.
73. Cavazzana-Calvo M., Payen E., Negre O., Wang G., Hehir K., Fusil F., et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010, 467:318-322.
74. Glocker E.O., Kotlarz D., Boztug K., Gertz E.M., Schaffer A.A., Noyan F., et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009, 361:2033-2045.
75. Cirak S., Arechavala-Gomeza V., Guglieri M., Feng L., Torelli S., Anthony K., et al. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 2011, 378:595-605.
76. Porter D.L., Levine B.L., Kalos M., Bagg A., June C.H. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011, 365:725-733.
77. Iguchi H., Kosaka N., Ochiya T. Secretory microRNAs as a versatile communication tool. Commun Integr Biol 2010, 3:478-481.
78. Keller S., Ridinger J., Rupp A.K., Janssen J.W., Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 2011, 9:86.
79. Michael A., Bajracharya S.D., Yuen P.S., Zhou H., Star R.A., Illei G.G., et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis 2010, 16:34-38.
80. Lasser C., O'Neil S.E., Ekerljung L., Ekstrom K., Sjostrand M., Lotvall J. RNA-containing exosomes in human nasal secretions. Am J Rhinol Allergy 2011, 25:89-93.
81. Luo S.S., Ishibashi O., Ishikawa G., Ishikawa T., Katayama A., Mishima T., et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod 2009, 81:717-729.
82. Malone C.D., Hannon G.J. Small RNAs as guardians of the genome. Cell 2009, 136:656-668.
83. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
84. Kumar P., Ban H.S., Kim S.S., Wu H., Pearson T., Greiner D.L., et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134:577-586.
85. Sibley C.R., Wood M.J. Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson's disease. PLoS One 2011, 6:e26194.
86. Bonetta L. RNA-based therapeutics: ready for delivery?. Cell 2009, 136:581-584.
87. Leuschner F., Dutta P., Gorbatov R., Novobrantseva T.I., Donahoe J.S., Courties G., et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 2011, 29:1005-1010.
88. McLachlan G., Davidson H., Holder E., Davies L.A., Pringle I.A., Sumner-Jones S.G., et al. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther 2011, 18:996-1005.
89. Lee J.S., Green J.J., Love K.T., Sunshine J., Langer R., Anderson D.G. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9:2402-2406.
90. Davis M.E., Zuckerman J.E., Choi C.H., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
91. Akao Y., Iio A., Itoh T., Noguchi S., Itoh Y., Ohtsuki Y., et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther 2011, 19:395-399.
92. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010, 285:17442-17452.
93. Lee Y.S., Kim S.H., Cho J.A., Kim C.W. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects. Exp Mol Med 2011, 43:281-290.
94. Mittelbrunn M., Gutierrez-Vazquez C., Villarroya-Beltri C., Gonzalez S., Sanchez-Cabo F., Gonzalez M.A., et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat Commun 2011, 2:282.
95. De La Pena H., Madrigal J.A., Rusakiewicz S., Bencsik M., Cave G.W., Selman A., et al. Artificial exosomes as tools for basic and clinical immunology. J Immunol Methods 2009, 344:121-132.
96. Dey D., Inayathullah M., Lee A.S., LeMieux M.C., Zhang X., Wu Y., et al. Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid. Biomaterials 2011, 32:4647-4658.
97. Chen T.S., Arslan F., Yin Y., Tan S.S., Lai R.C., Choo A.B., et al. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med 2011, 9:47.